Transcript Slide 1 - Elsevier Store

Chapter 6
The Hypothalamus—Pituitary—
Thyroid (HPT) Axis of Mammals
Copyright © 2013 Elsevier Inc. All rights reserved.
Figure 6-1 The mammalian thyroid. The thyroid gland is located in the neck region. It consists of many hollow
follicles, each of which is filled with a proteinaceous fluid called colloid which is secreted by the follicle cells.
Thyroxine synthesized by the follicle cells is stored in the colloid. The C-cells or parafollicular cells are of
ultimobranchial origin and secrete the calcium-regulating hormone, calcitonin (see Chapter 14). (Adapted with
permission from McNabb, F.M.A., “Thyroid Hormones,” Prentice Hall, Upper Saddle River, NJ, 1993.)
Copyright © 2013 Elsevier Inc. All rights reserved.
2
Figure 6-2A Thyroid and parathyroid glands. (A) Low magnification of compact parathyroid gland (above)
embedded in the thyroid gland consisting of colloid-filled follicles (below). (B) High magnification of thyroid
follicles with squamous epithelium surrounding colloid.
Copyright © 2013 Elsevier Inc. All rights reserved.
3
Figure 6-2B Thyroid and parathyroid glands. (A) Low magnification of compact parathyroid gland (above)
embedded in the thyroid gland consisting of colloid-filled follicles (below). (B) High magnification of thyroid
follicles with squamous epithelium surrounding colloid.
Copyright © 2013 Elsevier Inc. All rights reserved.
4
Figure 6-3 Thyroid hormone biosynthesis. The sodium iodide symporter (NIS) transports Na+ and I– across
the basolateral plasma membrane of a follicular cell. The Na+/K+ ATPase maintains the sodium diffusion gradient
required for operation of the NIS. The enzyme thyroid peroxidase (TPO) located at the apical surface is
responsible for activating I–, for iodinating thyroglobulin (Tgb), and for coupling iodinated tyrosines to form T 4.
Release of thyroid hormones requires engulfing colloid (endocytosis) to form intracellular endosomes that merge
with lysosomes to form an endolysosome. This results in degradation of Tgb and liberation of T 4 into the cytosol,
where a type-1 deiodinase (D1) converts some of it to T3 and rT3 (not shown). These products then pass from
the basal surface of the cell into the blood.
Copyright © 2013 Elsevier Inc. All rights reserved.
5
Figure 6-4 Worldwide location of iodide-poor regions. The shaded portions indicate the iodide-poor regions.
Copyright © 2013 Elsevier Inc. All rights reserved.
6
Figure 6-5 The cassava root is an important dietary staple in tropical countries but is rich in thiocyanate which
blocks iodide uptake by the thyroid gland.
Copyright © 2013 Elsevier Inc. All rights reserved.
7
Figure 6-6 Some thyroid inhibitors. (A) Thiourea, thiouracil, propylthiouracil (PTU), carbimazole, and
methimazole are all goitrogens that block iodide uptake and/or the iodination and coupling reactions. (B) Goitrin
is a naturally occurring goitrogen that is made from the precursor progoitrin by the enzyme myrosinase. (C)
Ipodate and amiodarone block liver deiodinases. PTU also blocks type-1 deiodinase activity.
Copyright © 2013 Elsevier Inc. All rights reserved.
8
Figure 6-7 Some environmental thyroid disrupting contaminants. Dioxins (A) and polychlorinated biphenyls
(PCBs) (B) arise from a number of diverse industrial sources and can alter normal thyroid hormone metabolism
and action. Polybrominated diphenyl ethers (PBDEs) (C) are ubiquitous contaminants in the environment that
arise mainly from fire-retardant materials. PBDEs have a striking structural resemblance to T 4 and T3 and have
been reported to alter plasma thyroid hormone levels and thyroid hormone metabolism. Chlorate (D) and
perchlorate (E) anions potently block thyroid iodide transport and therefore inhibit thyroid hormone synthesis.
They are found in the environment as a result of aerospace and military waste and agricultural use (chlorate is
applied as a defoliant).
Copyright © 2013 Elsevier Inc. All rights reserved.
9
Figure 6-8 Organic anion transport proteins that transport thyroid hormones across the blood–brain
barrier (BBB) and into neurons. Monocarboxylic acid transporter 8 (MCT8), organic anion transporting
polypeptide 1C1 (OATP1C1), and large neutral amino acid transporters 1 and 2 (LAT 1 and 2) transport T 3 and
T4 across the blood–brain barrier. Once transported across the bloodebrain barrier, T 4 is deiodinated to T3 by
neighboring astrocytes and then transported into neurons by MCT8. (Adapted with permission from Kinne, A. et
al., Thyroid Research, 4(Suppl. 1), 1–10, 2011.)
Copyright © 2013 Elsevier Inc. All rights reserved.
10
Figure 6-9 Thyroid hormones and development of the nervous system in humans. Note that many critical
events in the nervous system are correlated with periods of thyroid hormones secretion. (Adapted with
permission from Howdeshell, K.L., Environmental Health Perspectives, 110(Suppl. 3), 337–348, 2002.)
Copyright © 2013 Elsevier Inc. All rights reserved.
11
Box Figure 6A-1 Secondary structure of the human sodium iodide symporter (NIS) protein. Each of the 13
transmembrane domains is labeled by a roman numeral. Mutations in the NIS known to cause iodide transport
defects (ITDs) have led to a better understanding of the functional regions of the NIS protein as indicated.
Adapted with permission from Spitzweg, C., Morris, J.C., 2010. Genetics and phenomics of hypothyroidism and
goiter due to NIS mutations. Molecular and Cellular Endocrinology 322., 56-63.
Copyright © 2013 Elsevier Inc. All rights reserved.
12
Box Figure 6B-1 Incidence of thyroid cancer following the Chernobyl nuclear plant disaster of 1986.
(Adapted with permission from Demidchik, Y.E. et al., International Congress Series, 1299, 32–38, 2007 and
Cardis, E. et al., Journal of Radiation Protection 26, 127–140, 2006.)
Copyright © 2013 Elsevier Inc. All rights reserved.
13
Box Figure 6C-1 Formation of iodolipids by the thyroid gland. (A) Iodolactone is formed from iodination of
arachidonate. (B) 2-Iodohexadecanal is synthesized by iodination of the phospholipid plasmenylethanolamine.
Synthesis of both iodolipids by the thyroid gland requires
Copyright © 2013 Elsevier Inc. All rights reserved.
14
Box Figure 6D-1 Alternative routes for decarboxylation (removal of COOH) and biosynthesis of
thyronamines and dopamine. Recent studies indicate that an as of yet undiscovered “iodothyronine
decarboxylase” enzyme (question mark) is responsible for the decarboxylation of T 3 to 3-T1AM, the principle
thyronamine and one of two thyronamines (TAMS) found in vivo. (Adapted with permission from Hoefig, C.S. et
al., Molecular and Cellular Endocrinology, 349, 195–201, 2012.)
Copyright © 2013 Elsevier Inc. All rights reserved.
15
Box Figure 6D-2 Theoretical model for the potential role of thyronamines modulating T3 action in a target
cell. T3 and T4 are transported by various proteins (LAT2, MCT8, OATP14) into the target cell where they can
interact with the thyroid hormone receptor (TR) to alter transcription and protein synthesis. Alternatively, T 3 and
T4 can interact with a domain on the extracellular portion of the integrin receptor to elicit effects through the
protein kinase C and phospholipase signaling pathways. These effects can be blocked by an antagonist of the
thyroid hormone membrane receptor tetraiodothyroacetic acid (TETRAC). Thyronamines (TAMs) are ligands for
the G-protein-coupled receptor TAAR. TAMs can modulate cellular activity by activating this receptor and
elevating intracellular cyclic AMP levels. Abbreviations: αβ3 integrin, vitronectin receptor; D1,2, type 1 and type
2 deiodinase; ERK1/2, extracellular-signal-regulated kinases; LAT2, L-type amino acid transporter 2; MCT8,
monocarboxylate transporter 8; OATP14, organic anion transporter 14; PKC, protein kinase C; PLC,
phospholipase C; RXR, retinoic acid X receptor; TAAR, trace amine associated receptor; TRα1 (TRα1),
cytosolic variant of TR. (Adapted with permission from Piehl, S. et al., Endocrine Reviews, 32, 64–80, 2011.)
Copyright © 2013 Elsevier Inc. All rights reserved.
16